This suggested that miR-139 downregulation was not due to a loss of function of FUS, supporting recent work indicating that FUS-associated ALS is due to toxic gain of function (Korobeynikov et al., 2022; Sharma et al., 2016). The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.